{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:32:55Z","timestamp":1791999175833,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":4184,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1006\/viro.2001.1255","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T14:40:07Z","timestamp":1033915207000},"page":"151-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Human Cytotoxic T Lymphocyte Responses to Live Attenuated 17D Yellow Fever Vaccine: Identification of HLA-B35-Restricted CTL Epitopes on Nonstructural Proteins NS1, NS2b, NS3, and the Structural Protein E"],"prefix":"10.1006","volume":"293","author":[{"given":"Mary Dawn T.","family":"Co","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Terajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A.","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/viro.2001.1255_RF1","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1084\/jem.181.6.2037","article-title":"Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA B35 subtype molecules","volume":"181","author":"Beck","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1006\/viro.2001.1255_RF2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/161.6.1134","article-title":"Immunogenicity of a purified fragment of 17D yellow fever envelope protein","volume":"161","author":"Brandriss","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1006\/viro.2001.1255_RF3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1099\/0022-1317-67-2-229","article-title":"Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses","volume":"67","author":"Brandriss","year":"1986","journal-title":"J. Gen. Virol."},{"key":"10.1006\/viro.2001.1255_RF4","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1128\/jvi.63.12.5086-5091.1989","article-title":"Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes","volume":"63","author":"Bukowski","year":"1989","journal-title":"J. Virol."},{"key":"10.1006\/viro.2001.1255_RF5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.187.9.1395","article-title":"Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo","volume":"187","author":"Callan","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1006\/viro.2001.1255_RF6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"key":"10.1006\/viro.2001.1255_RF7","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1128\/jvi.69.9.5773-5780.1995","article-title":"Nucleotide sequence variation of the envelope protein gene identifies two distinct genotypes of yellow fever virus","volume":"69","author":"Chang","year":"1995","journal-title":"J. Virol."},{"key":"10.1006\/viro.2001.1255_RF8","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/eji.1830220905","article-title":"Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers","volume":"22","author":"Cheynier","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/viro.2001.1255_RF9","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1128\/JVI.73.9.7108-7116.1999","article-title":"Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: Comparison with anti-Epstein\u2013Barr virus responses and changes during antiretroviral therapy","volume":"73","author":"Dalod","year":"1999","journal-title":"J. Virol."},{"key":"10.1006\/viro.2001.1255_RF10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<38::AID-IMMU38>3.0.CO;2-2","article-title":"Altered ex vivo balance between CD28+ and CD28\u2212 cells within HIV-specific CD8+ T cells of HIV-seropositive patients","volume":"29","author":"Dalod","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/viro.2001.1255_RF11","first-page":"1","article-title":"Cytotoxic T cell effector and memory function in viral immunity","volume":"206","author":"Doherty","year":"1996","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1006\/viro.2001.1255_RF12","series-title":"Yellow Fever Vaccination","first-page":"115","article-title":"Mass yellow fever vaccination in French Africa south of the Sahara","author":"Durieux","year":"1956"},{"key":"10.1006\/viro.2001.1255_RF13","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1073\/pnas.87.7.2833","article-title":"Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: Frequency and nature of errors produced in amplification","volume":"87","author":"Ennis","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/viro.2001.1255_RF14","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.4049\/jimmunol.162.7.4163","article-title":"Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge","volume":"162","author":"Fu","year":"1999","journal-title":"J. Immunol."},{"key":"10.1006\/viro.2001.1255_RF15","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1021\/np50089a003","article-title":"Antiviral (RNA) activity of selected amaryllidaceae isoquinoline constituents and synthesis of related substances","volume":"55","author":"Gabrielsen","year":"1992","journal-title":"J. Nat. Proc."},{"key":"10.1006\/viro.2001.1255_RF16","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","article-title":"Recombinant chimeric yellow fever\u2013dengue type 2 virus is immunogenic and protective in nonhuman primates","volume":"74","author":"Guirakhoo","year":"2000","journal-title":"J. Virol."},{"key":"10.1006\/viro.2001.1255_RF17","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.4049\/jimmunol.162.12.7578","article-title":"Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species","volume":"162","author":"Jameson","year":"1999","journal-title":"J. Immunol."},{"key":"10.1006\/viro.2001.1255_RF18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm0898-975","article-title":"T-cell epitope mapping by flow cytometry","volume":"4","author":"Kern","year":"1998","journal-title":"Nat. Med."},{"key":"10.1006\/viro.2001.1255_RF19","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.149.10.3339","article-title":"Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis","volume":"149","author":"Koziel","year":"1992","journal-title":"J. Immunol."},{"key":"10.1006\/viro.2001.1255_RF20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1172\/JCI113911","article-title":"Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production","volume":"83","author":"Kurane","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1006\/viro.2001.1255_RF21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1084\/jem.170.3.763","article-title":"Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity","volume":"170","author":"Kurane","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1006\/viro.2001.1255_RF22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0042-6822(90)90391-4","article-title":"Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone","volume":"178","author":"Kuwano","year":"1990","journal-title":"Virology"},{"key":"10.1006\/viro.2001.1255_RF23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.186.6.859","article-title":"Rapid effector function in CD8+ memory T cells","volume":"186","author":"Lalvani","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1006\/viro.2001.1255_RF24","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.154.3.1287","article-title":"Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities","volume":"154","author":"Livingston","year":"1995","journal-title":"J. Immunol."},{"key":"10.1006\/viro.2001.1255_RF25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0042-6822(87)90141-3","article-title":"Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain)","volume":"161","author":"Lobigs","year":"1987","journal-title":"Virology"},{"key":"10.1006\/viro.2001.1255_RF26","first-page":"547","article-title":"Un cas d'encephalite apres vaccination anti-amarile par la souche 17D","volume":"36","author":"Louis","year":"1981","journal-title":"Pediatrie"},{"key":"10.1006\/viro.2001.1255_RF27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: A report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1006\/viro.2001.1255_RF28","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1128\/JVI.72.5.3999-4004.1998","article-title":"Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection","volume":"72","author":"Mathew","year":"1998","journal-title":"J. Virol."},{"key":"10.1006\/viro.2001.1255_RF29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/9.1.165","article-title":"Yellow fever: a medically neglected disease. Report on a seminar","volume":"9","author":"Monath","year":"1987","journal-title":"Rev. Infect. Dis."},{"key":"10.1006\/viro.2001.1255_RF30","series-title":"Vaccines","first-page":"815","article-title":"Yellow Fever","author":"Monath","year":"1999"},{"key":"10.1006\/viro.2001.1255_RF31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0092-1157(81)80036-4","article-title":"A clinical study of stabilized 17D strain live attenuated yellow fever vaccine","volume":"9","author":"Moss-Blundell","year":"1981","journal-title":"J. Biol. Stand."},{"key":"10.1006\/viro.2001.1255_RF32","first-page":"1313","article-title":"A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles","volume":"81","author":"Nanan","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1006\/viro.2001.1255_RF33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF02421534","article-title":"The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms","volume":"30","author":"Ooba","year":"1989","journal-title":"Immunogenetics"},{"key":"10.1006\/viro.2001.1255_RF34","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/1521-4141(200009)30:9<2713::AID-IMMU2713>3.0.CO;2-4","article-title":"High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease","volume":"30","author":"Pathan","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/viro.2001.1255_RF35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0042-6822(92)90317-I","article-title":"Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis","volume":"187","author":"Pincus","year":"1992","journal-title":"Virology"},{"key":"10.1006\/viro.2001.1255_RF36","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1172\/JCI118133","article-title":"Env-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids","volume":"96","author":"Pinto","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1006\/viro.2001.1255_RF37","first-page":"772","article-title":"Reactions post-vaccinales. A la vaccination anti-amarile","volume":"79","author":"Pivetaud","year":"1986","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"10.1006\/viro.2001.1255_RF38","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull. World Health Organ."},{"key":"10.1006\/viro.2001.1255_RF39","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1099\/0022-1317-71-8-1697","article-title":"Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b","volume":"71","author":"Putnak","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1006\/viro.2001.1255_RF40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1399-0039.1995.tb02472.x","article-title":"The relative distribution of B35 alleles and their IEF isotypes in a HLA-B35-positive population","volume":"46","author":"Ragupathi","year":"1995","journal-title":"Tissue Antigens"},{"key":"10.1006\/viro.2001.1255_RF41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.510310237","article-title":"Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen","volume":"31","author":"Rahman","year":"2000","journal-title":"Hepatology"},{"key":"10.1006\/viro.2001.1255_RF42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF00172063","article-title":"MHC ligands and peptide motifs: First listing","volume":"41","author":"Rammensee","year":"1995","journal-title":"Immunogenetics"},{"key":"10.1006\/viro.2001.1255_RF43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"10.1006\/viro.2001.1255_RF44","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jama.1996.03540140045025","article-title":"Yellow fever\u2014A decade of reemergence","volume":"276","author":"Robertson","year":"1996","journal-title":"J. Am. Med. Assoc."},{"key":"10.1006\/viro.2001.1255_RF45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"key":"10.1006\/viro.2001.1255_RF46","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1172\/JCI4314","article-title":"Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi","volume":"102","author":"Rowland-Jones","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1006\/viro.2001.1255_RF47","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/0140-6736(93)93063-7","article-title":"HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant","volume":"341","author":"Rowland-Jones","year":"1993","journal-title":"Lancet"},{"key":"10.1006\/viro.2001.1255_RF48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/vim.1993.6.229","article-title":"Protective cross reactive epitope on the nonstructural protein NS1 of influenza A virus","volume":"6","author":"Saikh","year":"1993","journal-title":"Viral Immunol."},{"key":"10.1006\/viro.2001.1255_RF49","series-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"1989"},{"key":"10.1006\/viro.2001.1255_RF50","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/jvi.60.3.1153-1155.1986","article-title":"Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1","volume":"60","author":"Schlesinger","year":"1986","journal-title":"J. Virol."},{"key":"10.1006\/viro.2001.1255_RF51","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.1993.1015","article-title":"The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice","volume":"192","author":"Schlesinger","year":"1993","journal-title":"Virology"},{"key":"10.1006\/viro.2001.1255_RF52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s002510050179","article-title":"Refined peptide HLA-B*3501 binding motif reveals differences in 9-mer to 11-mer peptide binding","volume":"45","author":"Schonbach","year":"1996","journal-title":"Immunogenetics"},{"key":"10.1006\/viro.2001.1255_RF53","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0035-9203(38)90045-8","article-title":"Yellow fever: Present situation (October 1938) with special reference to South America","volume":"32","author":"Soper","year":"1938","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1006\/viro.2001.1255_RF54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00186615","article-title":"Motif of HLA B3503 peptide ligands","volume":"43","author":"Steinle","year":"1995","journal-title":"Immunogenetics"},{"key":"10.1006\/viro.2001.1255_RF55","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.4049\/jimmunol.138.6.1657","article-title":"NK susceptibility varies inversely with target cell class I HLA antigen expression","volume":"138","author":"Storkus","year":"1987","journal-title":"J. Immunol."},{"key":"10.1006\/viro.2001.1255_RF56","series-title":"Yellow Fever Vaccination","first-page":"143","article-title":"Reactions following vaccination against yellow fever","author":"Stuart","year":"1956"},{"key":"10.1006\/viro.2001.1255_RF57","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4269\/ajtmh.1962.11.562","article-title":"Immunological studies with group B arthropod borne viruses: Effect of prior infection with japanese encephalitis virus on the viremia in human subjects following administration of 17D yellow fever vaccine","volume":"11","author":"Sweet","year":"1962","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1006\/viro.2001.1255_RF58","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.4049\/jimmunol.162.3.1827","article-title":"A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers","volume":"162","author":"Tan","year":"1999","journal-title":"J. Immunol."},{"key":"10.1006\/viro.2001.1255_RF59","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1128\/JVI.74.17.8094-8101.2000","article-title":"Chimeric yellow fever\/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response","volume":"74","author":"van Der Most","year":"2000","journal-title":"J. Virol."},{"key":"10.1006\/viro.2001.1255_RF60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17D vaccine in Brazil: A report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1006\/viro.2001.1255_RF61","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/viro.2001.1255_RF62","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4269\/ajtmh.1962.11.550","article-title":"Immunological studies with group B arthropod-borne viruses: Broadened neutralizing antibody spectrum induced by strain 17D yellow fever vaccine in human subjects previously infected with japanese encephalitis virus","volume":"11","author":"Wisseman","year":"1962","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1006\/viro.2001.1255_RF63","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.4049\/jimmunol.148.6.1941","article-title":"The HLA-A,B \u201cnegative\u201d mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon","volume":"148","author":"Zemmour","year":"1992","journal-title":"J. Immunol."},{"key":"10.1006\/viro.2001.1255_RF64","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.4049\/jimmunol.163.5.2754","article-title":"Partial agonist effect influences the CTL response to a heterologous dengue virus serotype","volume":"163","author":"Zivny","year":"1999","journal-title":"J. Immunol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682201912553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682201912553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:14:19Z","timestamp":1758582859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682201912553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0042682201912553"],"URL":"https:\/\/doi.org\/10.1006\/viro.2001.1255","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Cytotoxic T Lymphocyte Responses to Live Attenuated 17D Yellow Fever Vaccine: Identification of HLA-B35-Restricted CTL Epitopes on Nonstructural Proteins NS1, NS2b, NS3, and the Structural Protein E","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/viro.2001.1255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science (USA). All rights reserved.","name":"copyright","label":"Copyright"}]}}